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Polypeptide synthesis using either phenylalanine or 
lysine  was initiated on Escherichia coli ribosomes; then 
the position and conformation of the nascent peptide 
were monitored by fluorescence techniques. To this 
end, fluorophores had been attached to the amino ter- 
minus  of each nascent peptide, and  major differences 
were observed as chain extension occurred. Polyphen- 
ylalanine appeared to build up as a hydrophobic mass 
adjacent  to the peptidyl transferase center while poly- 
lysine apparently was extended directly from the ri- 
bosome into the surrounding solution. An explanation 
for these differences may  be provided by the physical 
and chemical properties of each polypeptide. These 
properties may  be responsible for the route by which 
each peptide exits the peptidyl transferase center as 
demonstrated by the different sensitivity of each to 
inhibition by erythromycin. 
Very little is known of the mechanisms involved in the 
establishment of the secondary and tertiary structures of 
proteins as they are synthesized on the ribosome. Correct 
folding of a peptide  into  the discrete, often  metastable  con- 
formation of a native, soluble enzyme probably occurs in 
parallel with linear  synthesis  and  is likely to be profoundly 
influenced by the physical nature of the peptide as  it emerges 
from  the ribosome as well as by the physical character of the 
adjacent regions of the ribosome through which it passes. 
Influences of external  factors  such  as  those involved in  the 
cotranslation of the  nascent  peptide  into or through cellular 
membranes  present  additional  features to this  general  prob- 
lem. 
The  nascent peptide is generated at  the  peptidyl  transferase 
center of the large  ribosomal subunit by the  sequential  addi- 
tion of amino acids from aminoacyl-tRNA to the carboxyl 
terminus of the growing polypeptide. The  tRNA  binding  sites 
are located  between the ribosomal subunits,  and  the  peptidyl 
transferase  center is on  the  interfacing surface of the large 
subunit  near  its  central  protuberance. Growing evidence sup- 
ports  the  notion  that  at  least some nascent  peptides  synthe- 
sized in vivo emerge from the surface of the ribosome at a site 
called the exit domain located on the outer surface of the 
large ribosomal subunit at a point distal to the peptidyl 
transferase center (1). A segment of 30-35 amino acids on 
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nascent peptides is protected from proteolytic degradation 
(2-4). This corresponds to a distance of about 50 A for a 
polypeptide forming an a-helix. This peptide segment may 
span  the  distance between the peptidyl transferase  center  and 
the exit domain; however, there is no direct evidence to 
indicate how the  nascent  peptide  transverses  the  intervening 
distance between these two points. A tunnel  has been reported 
to span the large ribosomal subunit from the interfacing 
surface  to a point  on  the  outer surface ( 5 ) .  The  outer  portion 
of this tunnel appears to be in the region of the nascent 
peptide  exit  domain. I t  was suggested that  the  nascent  peptide 
may follow this  tunnel  to  the  exit  domain for  some, if not all, 
newly synthesized  proteins. 
Erythromycin blocks the synthesis of most but not all 
polypeptides on Escherichia coli ribosomes by binding to a 
site  that is very close to  the  amino acid of aminoacyl-tRNA 
in  the  peptidyl  transferase  center (6). It  has been suggested 
that the antibiotic may bind to the 50 S subunit at the 
entrance  to  the  tunnel  mentioned above (7) thereby blocking 
extension of the newly formed nascent peptide.  However, the 
fact  that  erythromycin does not  inhibit  the  formation of all 
polypeptides clearly indicates that another or an alternate 
mechanism must exist. Ryabova and co-workers (8) have 
questioned  the xistence of a tunnel  spanning  the 50 S subunit 
through which the  nascent  peptide passes. They  find  that  the 
nascent  peptide is accessible to  antibodies from  a point very 
near the peptidyl transferase center. Here, we report the 
results from our own studies primarily using fluorescence 
techniques  to  characterize  the  extension of phenylalanyl  and 
lysyl polypeptides as  they  are formed on E. coli ribosomes. 
The sensitivities of the fluorescent probes used in these 
studies to environmental  conditions  in  their  immediate vicin- 
ity have  been  used to  monitor  changes in the relative positions 
of the  amino  termini of polyphenylalanine and polylysine at  
various  points  prior  to  and  after  synthesis of the  first  peptide 
bond. Results with erythromycin  and a  fluorescent  derivative 
of erythromycin support the hypothesis that the antibiotic 
binds very near to the amino terminus of short nascent 
peptides a t  a site that is blocked by the peptide as it is 
extended.  Polyphenylalanine  can be formed  in the presence 
of erythromycin,  but polylysine synthesis  is blocked by the 
antibiotic.  The  results suggest that  the difference  in sensitiv- 
ity may be due to a difference in the physical properties or 
conformation of the nascent peptides. The data appear to 
indicate  that  neither  polyphenylalanine nor polylysine nas- 
cent peptides are restrained in a tunnel but rather extend 
directly into  the solution surrounding the ribosome from a 
region near  the  peptidyl  transferase  center. 
EXPERIMENTAL  PROCEDURES 
Materials and Chemicals--E. coli K12 strain A19 was provided to 
us by Drs. K. Nierhaus  and H. G. Wit.tmann,  Berlin.  Erythromycy- 
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lamine was a gift  from Dr. Robert  Hamill of Lilly. E. coli tRNAPh' 
and  tRNALy" were from Subriden RNA,  Inc.  (Rollingbay, WA).  CPM' 
and CITC were from Molecular Probes, Inc. (Junction City, OR). 
IAEDANS,  yeast tRNAPh',  puromycin  dichloride, poly(U), poly@), 
ATP, GTP, N-hydroxysuccinimide, erythromycin, Sephadex, and 
Sepharose  products were purchased from  Sigma. DE23 cellulose  was 
from  Whatman. N,N'-Dicyclohexylcarbodiimide was from  Schwarzl 
Mann.  ['4C]Phenylalanine  and [14C]lysine were from ICN Biomedi- 
cals, Inc. (Irvine, CA). Phenol  and  dimethylformamide were from J. 
T. Baker Inc. and were redistilled  before use. HPLC grade methanol 
was from  Fisher. All other chemicals were of reagent grade. 
Preparation of E. coli Ribosomal Subunits-The growth and  main- 
tenance of E. coli K12, strain A19, and  the  isolation of ribosomes and 
ribosomal subunits have  been  described  previously (9). 
Poly(U)-dependent and Poly(A)-dependent Peptide Synthesis-The 
poly(U)-directed  synthesis of polyphenylalanine  has been  described 
previously and provides a convenient  measure of ribosome activity 
(9). To accommodate the use of fluorescent aminoacyl-tRNA and 
erythromycin derivatives, some modifications of this  published  pro- 
cedure were made. The postribosomal  supernatant  fraction (S-150), 
used in previous studies as  the  source of aminoacyl-tRNA  synthetases 
and elongation  factors,  was chromatographed  on  DE23 cellulose to 
remove nucleic acid and  other  materials  that  interfere  with  measure- 
ments of fluorescence from some probes. A 1.2 X 30-cm column 
containing DE23 cellulose was equilibrated with 20 mM Tris-HC1 
(pH 7.5), 10 mM  MgC12, 50 mM NH4Cl, 0.5 mM EDTA, 2 mM 0- 
mercaptoethanol, and the sample was applied after dialysis in  the 
same solution. After extensive washing, a fraction containing the 
synthetases  and  elongation  factors was eluted  with  the  same  solution 
to  which NH4Cl was added  to give a final  concentration of  250  mM. 
To facilitate  the  nonenzymatic  initiation of polyphenylalanine  syn- 
thesis,  AcPhe-tRNA  or a fluorescent  analogue of AcPhe-tRNA was 
preincubated  with ribosomes. The fluorescent  derivative was used at  
about 10-25% of the ribosome concentration to ensure maximum 
tRNA  binding  whereas  AcPhe-tRNA was at about  the  same  concen- 
tration  as  the ribosomes to allow the  maximum  proportion of ribo- 
somes  to  initiate polypeptide synthesis. A typical reaction mixture 
contained 50 mM Tris-HCI  (pH 7.5), 100 mM NH4C1, 15 mM 
Mg(OAc),, 5 mM 0-mercaptoethanol, 200 pg/ml poly(U), 7.5 A,,, 
units/ml 30 S ribosomal subunits, 14 A260 units/ml  50 S ribosomal 
subunits,  and  the  appropriate  amount of AcPhe-tRNA  or  its analogue. 
This  mixture was incubated a t  35  "C for 10  min to  allow for the  tRNA 
species  used to  bind to  the ribosomes. The reaction was then  made 
to 2 mM ATP, 0.2 mM GTP, 2.5  mM dithioerythritol, 1.6 mg/ml 
creatine phosphate, and 7.5 A260 units/ml unfractionated E. coli 
tRNA.  Creatine  phosphokinase was then  added  to a final  concentra- 
tion of 30 wg/ml and S-150 was added to  900 pg/ml. Polymerization 
was initiated by adding  ['Tlphenylalanine  to give 45 p ~ .  Polyphen- 
ylalanine  synthesis was a t  20 "C  in  the  temperature-regulated  sample 
compartment of the fluorometer unless otherwise indicated. The 
amount of [I4C]phenylalanine incorporated was determined by re- 
moving aliquots from the  reactions for trichloroacetic acid precipita- 
tion.  ["CIPhe-tRNA was  hydrolyzed  by incubating  the  samples  with 
0.1 M NaOH  prior  to  trichloroacetic  acid  precipitation. 
Poly(A)-directed polylysine synthesis was carried  out  as described 
for polyphenylalanine  synthesis  except for the  minor modifications 
noted below. Poly(A), used as  an  mRNA  at 40 rg/ml or less, was 
heated to 70 "C and rapidly cooled before addition to the  reaction 
mixture. The initiation of polylysine synthesis was carried  out 
nonenzymatically  using either AcZLys-tRNA or its  fluorescent deriv- 
ative,  aAc-tCPM-SAcLys-tRNA,  as described  above  for AcPhe- 
tRNA.  The  rest of the  reaction was set  up exactly as  with  polyphen- 
ylalanine  synthesis  except  that  the  tRNA hydrolysis step was omitted 
' The abbreviations used are: CPM, 3-(4-maleimidophenyl)-7- 
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mido)ethylamino]-1-naphthalenesulfonic acid;  aAc-&PM-SAcLys- 
tRNA,  Lys-tRNA  that was mercaptoacetylated at  its  +amino group, 
reacted with CPM, and acetylated at its a-amino group; CPM- 
SAcPhe-tRNA, Phe-tRNA that was mercaptoacetylated at its a- 
amino group and  then  reacted  with  CPM;  AEDANS-SAcPhe-tRNA, 
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before trichloroacetic acid precipitation. For this reason, a control 
reaction was performed with each polylysine synthesis to use as a 
background so that radioactivity contributed by [14C]Lys-tRNA could 
be subtracted. 
Labeling of Yeast Phe-tRNA with CPM  and IAEZIANS-Labeling 
of the  a-amino  group of yeast  Phe-tRNA will be described in more 
detail elsewhere?  Briefly,  a mercaptoacetyl group was introduced at  
the  a-amino group of Phe-tRNA by reaction of the  aminoacyl-tRNA 
with  the succinimidyl ester of dithiodiglycolic acid, the  latter having 
been prepared by the dicyclohexylcarbodiimide method  (10).  Subse- 
quently  the disulfide bond was  reduced to give a free  sulfhydryl. CPM 
or  IAEDANS was then  reacted  with  the  resulting sulfhydryl group 
for 30 min a t  35 "C in 100 mM Hepes-KOH (pH 8.0) with a final 
probe  concentration of 2 mM. Differences in  the labeling  procedures 
for CPM  and  IAEDANS  based  on  the difference in solubility  of  each 
compound will be described in  detail elsewhere as will the  purification 
of the labeled tRNAs by reversed-phase  HPLC.* 
M e l i n g  of E. coli Lys-tRNA with CPM-In order  to  introduce a 
sulfhydryl group specifically at  the r-amino group of E. coli Lys- 
tRNA,  it was reacted  with  the succinimidyl ester of dithiodiglycolic 
acid essentially as described by Johnson  et al. (11) for reaction of 
Lys-tRNA  with succinimidyl acetate. The reaction  mixture  contained 
0.1 M potassium  phosphate  (pH 7.0) and  10 A260 units/ml  [14C]Lys- 
tRNA. Succinimidyl  dithiodiglycolate was added to 80 mM followed 
quickly by sufficient 8 M KOH  to  bring  the  final  pH  to 11.4. The 
reaction was allowed to  proceed for 15 s a t  0 "C  after which the  pH 
was lowered to 5 with glacial acetic  acid. From  this  point,  the labeling 
with CPM proceeded exactly as described for Phe-tRNA. cCPM- 
SAcLys-tRNA was purified by reversed-phase  HPLC  on a Beckman 
Ultrapore CS column. The column was equilibrated  with 20 mM Tris 
HOAc (pH 5.5), 10 mM Mg(OAc),, and 400 mM NaC1. Elution was 
with a discontinuous  gradient of methanol  with  the buffer and  salt 
concentrations being  held constant.  The  rCPM-SAcLys-tRNA eluted 
a t  39% methanol.  When desired, the  a-amino group of &PM- 
SAcLys-tRNA was acetylated by the  method of Rappoport  and  Lap- 
idot  (12). 
Preparation of Ac2Lys-tRNA and AcPhe-tRNA-Yeast tRNAPhe 
was aminoacylated as described  previously (13) except  that a 0.5 M 
KC1 salt wash of rabbit reticulocyte ribosomes was used as the 
aminoacyl-tRNA  synthetase source (14). 
E. coli tRNALYs was charged with lysine in a similar reaction 
containing 50 mM Tris-HCI (pH 7.5), 10 mM Mg(OAc),, 2.5 mM 
dithioerythritol,  50 mM NHICl,  30 pM ["Cjlysine, 3.6 mM ATP,  10 
Ase0 units/ml E. coli tRNALy", and  about 200 pg/ml $150 fraction 
that had been subjected to DE23 cellulose chromatography. The 
reaction mixture was incubated for 15 min at  35 "C. When the 
incubation was completed,  2 M NaOAc (pH 5.0) was added  to give a 
final concentration of 0.2 M, and the mixture was extracted with 
phenol. The aqueous  portion was then  precipitated  three  times with 
3  volumes of ethanol. 
For use in  the nonezymatic initiation of polypeptide synthesis,  the 
Phe-tRNA  and  Lys-tRNA were acetylated essentially according to  
Rappoport and Lapidot (12). The acetylation reaction was carried 
out  in 0.1 M triethanolamine HCI (pH 7.8), 6 mM Mg(OAc)s, 10 A2m 
units/ml  Phe-  or  Lys-tRNA,  and 10  mg/ml  succinimidyl acetate  that 
was added from a 120 mg/ml stock solution prepared in dimethyl- 
formamide. The reaction proceeded a t  0 "C for 30 min a t  which time 
the mixture was made  to 0.2 M NaOAc (pH 5.0) and  precipitated with 
3 volumes of ethanol. The  ethanol  precipitation was repeated twice. 
AcPhe-tRNA and deacylated tRNAph' were separated by C,, re- 
versed-phase  HPLC  as described  previously (15). Ac,Lys-tRNA  was 
separated from  deacylated tRNA  and  Lys-tRNA  that  had  not been 
acetylated completely by reversed-phase HPLC using a Beckman 
System Gold HPLC  and a Beckman  Ultrapore Ca column (0.46 X 25 
cm).  The  sample was loaded in 20 mM Tris-HOAc  (pH  5.5),  10 mM 
Mg(OAc),, and 400 mM NaCl after  the column had been  equilibrated 
with  the  same buffer. A discontinuous  gradient of methanol  in  the 
same solution was used for elution, Ac,Lys-tRNA eluting at  15% 
methanol. 
Nonenzymalic Formation of Diphenylalanine and Dilysine-Bind- 
ing of AcPhe-tRNA, Ac2Lys-tRNA, and  the fluorescent  analogues of 
each of these  to  the ribosomal P site was carried  out by a  modification 
of the procedure of Wurmbach  and  Nierhaus  (16). As described above, 
initiation of polypeptide synthesis  with  the fluorescent  derivatives  of 
aminoacyl-tRNA was carried  out a t  a concentration of the derivative 
' Odom, 0. W., Picking, W. D., Tsalkova, T., and Hardesty, B. 
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which was much lower than  that of the ribosomes to  ensure  that a 
high proportion of the  acyl-tRNA was bound. After  binding  the N-  
blocked aminoacyl-tRNA to the puromycin-reactive site, a second 
aminoacyl-tRNA was bound nonenzymatically in a similar  fashion to  
the  puromycin-nonreactive  site  (the A site according to  the classical 
model). When  the  N-blocked  aminoacyl-tRNA  bound first was flu- 
orescently  labeled, the second aminoacyl-tRNA was added a t  a con- 
centration  approximately  equal to  the ribosome concentration. 
Preparation of CITC-Erythromycin  and  the  Binding of Labeled and 
Unlabeled Erythromycin-CITC-erythromycin was prepared from er- 
ythromycylamine as described in detail elsewhere.' The binding of 
labeled erythromycin reached rapid equilibrium a t  35 "C and was 
carried  out  in  the  presence of N-blocked  aminoacyl-tRNA  with  little 
or no interference. Previous  results  indicated  that  CITC-erythromy- 
cin bound to  the ribosomes with a K, of 8 nM3 which is  similar  to  the 
K d  of the unmodified antibiotic  (17). 
To measure the effect of polylysine synthesis on CITC-erythro- 
mycin fluorescence, 0.26 p~ CITC-erythromycin was bound to 0.6 
pM ribosomes in 50 mM Tris-HC1 (pH 7.5), 15 mM Mg(OAc),, 100 
mM NH4C1, and 5 mM (f-mercaptoethanol for 5 min a t  35 "C. Ac2Lys- 
1.RNA was then bound in the presence of poly(A) for subsequent 
initiation of polylysine synthesis  as described  above. Steps  after  the 
initial  binding of CITC-erythromycin were performed  directly in  the 
cuvettes used for fluorescence measurements. 
The ability of CITC-erythromycin to be exchanged for excess 
unlabeled erythromycin when the former had been prebound to  
ribosomes prior to initiation of polyphenylalanine synthesis was 
measured to  ascertain  the  fate of the  antibiotic  after  the  synthesis of 
a  peptide whose synthesis  it is unable  to  inhibit.  CITC-erythromycin 
(0.26 PM) was bound to 1 p~ ribosomes in  the  cuvette  to be used  for 
fluorescence measurements exactly as described above. The poly(U)- 
directed  synthesis of polyphenylalanine was then  initiated.  After 30 
min at  35 "C, unlabeled erythromycin was added  in a 20-fold excess 
over CITC-erythromycin and in a 5-fold excess over the ribosome 
concentration. The  amount of CITC-erythromycin  remaining  bound 
over time was measured as a function of anisotropy  and was calculated 
as described in  the figure  legends. 
Isolation of Ribosomes with Bound tRNA and  Nascent  Peptides by 
Gel Filtration-In some cases, it was necessary to eliminate any 
contribution  to fluorescence measurements of the  portion of labeled 
N-blocked aminoacyl-tRNA that was not  bound  to  the ribosomes. 
Reaction  mixtures  containing ribosomes with  bound  tRNA or nascent 
chains were isolated by gel filtration. A 4-ml column (0.7 X 10 cm) 
containing Sephacryl S-300 was equilibrated  with 50 mM Tris-HC1 
(pH 7.5), 100 mM NH,CI, 15 mM Mg(OAcI2, and 5 mM P-mercapto- 
ethanol.  The  binding of N-blocked  aminoacyl-tRNA  and  the  forma- 
tion of nascent peptides were as described above except that the 
reaction volume was reduced from 0.5 to 0.2 ml. Fractions of 0.5 ml 
were collected, and  their  absorbance  at 260 nm  and  associated radio- 
activity was measured.  Fluorescence studies were then  conducted  on 
the ribosome peak fraction which eluted in the void volume well 
ahead of free tRNA  and ribosome-unassociated proteins. 
Sephadex G-15 Gel Filtration of Polylysine Nascent Peptides-To 
examine  the relative sizes of the polylysine nascent  peptide  chains, 
polylysine synthesis was initiated with aAc-cCPM-SAcLys-tRNA  in 
the presence or absence of excess  unlabeled erythromycin.  The ribo- 
somes bearing bound  tRNA  nascent  peptide  chains were then isolated 
on Sephacryl S-300 for fluorescence measurements as already de- 
scribed. These ribosome fractions were then  brought  to a final  con- 
centration of 0.2 M NaOH  to hydrolyze  all acyl-tRNA  present,  neu- 
tralized with glacial acetic  acid, and briefly centrifuged to remove any 
particulate material. To separate components of molecular mass 
greater  than  approximately 1,000 Da from smaller  components,  the 
samples were applied to a 16-ml  Sephadex  G-15  column (1 X 20 cm) 
equilibrated with 50 mM Tris-HC1  (pH 7.5), 15 mM MgCI,, and 100 
InM NH4C1. Fractions of 0.5 ml were collected and  the  presence of 
lysine  monitored by determination of [I4C]lysine in a 25-pl aliquot of 
each fraction. Elution of free ["C]lysine from the  same column was 
also determined. 
Fluorescence Measurements-A model 8000 photon-counting spec- 
trofluorometer from SLM Instruments, Inc. (Urbana, IL) was used 
to  carry out steady-state fluorescence measurements as described 
previously (18). Spectral  data were acquired at  2-nm  intervals  with a 
scanning rate of 2 or 5 s/wavelength increment. The wavelength 
dependence of the  sensitivity of the  photomultiplier was automati- 
:' Odom, 0. W., Picking, W. D., and  Hardesty, B. (1991) Biochem- 
istry, in press. 
cally corrected,  and  all  measurements were made a t   an  absorbance of 
less than 0.1 at the  excitation wavelength in a  volume of 0.5 ml a t  
20 "C unless  otherwise  indicated. Steady-state fluorescence  polariza- 
tion  and  anisotropy  measurements were made  with SLM  fluorometer 
as described  previously (19). 
When the fluorescence  from CITC-erythromycin or the CPM 
derivatives was  measured, excitation was at  385 nm. For  the fluores- 
cence polarization  measurements used to  determine  anisotropy,  the 
emission  wavelength  was 470 nm for the  CITC  and  CPM derivatives. 
AEDANS fluorescence was measured  with an excitation wavelength 
of 360 nm,  and  the emission for AEDANS fluorescence anisotropy 
and  intensity was at  480 nm. 
RESULTS 
Initiation of Polyphenylalanine Synthesis with Fluorescent 
Acyl-tRNA-Fluorescence anisotropy, fluorescence intensity, 
and emission  maximum were measured  for  AEDANS- 
SAcPhe-tRNA and CPM-SAcPhe-tRNA after initiation of 
polypeptide synthesis with these  tRNA species. The fluores- 
cence properties of CPM  and  AEDANS  are greatly  influenced 
by the environment immediately surrounding the probes. 
Thus,  these  types of measurements provide  a way to  monitor 
changes in the environment of the amino terminus of the 
nascent  peptide  as  it  is  extended  during  synthesis  on ribo- 
somes. The effects of binding  to ribosomes on  anisotropy  and 
fluorescence intensity of AEDANS-  and  CPM-SAcPhe-tRNA 
are shown in Fig. 1, A and B, respectively. Binding causes 
AEDANS anisotropy to  increase from 0.03 to about 0.25 
whereas  CPM  anisotropy  increases from 0.17 to  about 0.37. 
The higher numerical values  for the fluorescence anisotropy 
of CPM  apparently reflect its  shorter fluorescence lifetime. 
These  results  indicate  that  the aminoacyl portion of amino- 
acyl-tRNA is held rather rigidly in  the peptidyl transferase 
center.  Upon  binding  to ribosomes, the fluorescence intensity 
of the  AEDANS derivative of Phe-tRNA decreases about 30% 
with a shift  in  the emission maximum  from  about 502 to 490 
nm (Fig. IC) whereas the intensity of CPM fluorescence 
increases more than 30%, and  the emission  maximum shifts 
toward the blue from 481 to 471 nm (Fig. 1D). These are 
approximately the changes in fluorescence which would be 
observed if the probes were taken from  water to 70% ethanol. 
Such changes in the fluorescence intensity and emission 
maximum for each fluorescent analogue indicate that the 
peptidyl  transferase  center is hydrophobic in nature as was 
suggested previously.3 
Upon  initiation of polyphenylalanine  synthesis,  the  aniso- 
tropy of bound  AEDANS-SAcPhe  drops rapidly, indicating a 
decrease in  the rigidity with which it  is  bound  to  the ribosome 
(Fig. 1A). This momentary drop is followed by a gradual 
increase  in  anisotropy,  indicating  that  extension of the  pep- 
tide  restrains  the  movement of the  amino-terminal probe.  A 
similar  although  much  smaller  drop  in  anisotropy  is ob erved 
when CPM-SAcPhe-tRNA  is used instead of the  AEDANS 
derivative (Fig. 1B). Fig. 1, A and B, also shows the corre- 
sponding changes in the intensity of fluorescence from  the 
AEDANS and CPM derivatives during the course of poly- 
phenylalanine  synthesis.  There is a small  initial  drop  in  the 
intensity of both  CPM  and  AEDANS fluorescence. Experi- 
ments  in which the  rate of polymerization is slowed indicate 
that  the  drop  in  intensity occurs  slightly ahead of the  drop  in 
anisotropy  (results  not  shown).  This  initial  drop  is followed 
by a gradual increase in fluorescence intensity  as  the peptide 
is  elongated  further. Also, at  early  stages of polymerization 
the emission maximum of AEDANS  (but  not  that of CPM) 
shifts to the red (results not shown). Considered together, 
these  results for anisotropy,  intensity,  and emission  maximum 
appear to indicate that the probe on the amino-terminal 
residue of polyphenylalanine  passes quickly into a  relatively 
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FIG. 1. Changes in the fluorescence properties of AEDANS 
and CPM attached to the amino terminus of a growing poly- 
phenylalanine nascent peptide. In panels A and B ,  anisotropy 
are followed for AEDANS-SAcPhe-tRNA ( A )  and CPM-SAcPhe- 
(open symbols) and relative fluorescence intensity (closed symbols) 
tRNA ( B )  when free in solution ( f ree   tRNA) ,  bound to ribosomes 
(time = 0 min),  and  throughout  the  synthesis of nascent  polyphen- 
ylalanine  (shown  with circles). Control  samples (shown  with squares) 
were treated identically except that the S-150 fraction (added in 
experimental samples a t  0 min) was omitted.  In  each case, nascent 
peptides approaching 100 phenylalanine residues in  length were pro- 
duced (data not  shown). Panels C and D show the emission spectra 
of A and E ,  respectively, of free tRNA (. . . . . .), ribosome-bound 
tRNA (-), and  after polyphenylalanine synthesis was completed 
(- - -). Panel C, AEDANS-SAcPhe-tRNA; panel D, CPM-SAcPhe- 
tRNA. 
more polar environment  in which it has higher flexibility as 
a very short peptide is formed. Subsequently, its movement 
becomes more restrained, and  its environment becomes in- 
creasingly hydrophobic as the nascent peptide is extended. 
Initial changes in these fluorescence properties may reflect 
movement of the amino terminus of the nascent peptide out 
of the peptidyl transferase center. Over time, the progressive 
increases in anisotropy and fluorescence intensity suggest that 
the probes become increasingly confined in an environment 
of increasing hydrophobicity. The blue shifts in emission 
maxima after extensive polymerization with AEDANS (Fig. 
IC)  and especially with CPM (Fig. 1D) also indicate an 
extremely hydrophobic environment. The length of the nas- 
cent polyphenylalanine chains in these  studies has been esti- 
mated to approach 100 amino acids. This far exceeds the 
predicted length from the peptidyl transferase  center to  the 
peptide  exit domain, suggesting that  the observed fluorescence 
properties of the amino-terminal labels are  not due to restric- 
tion within any particular region of the ribosome. Instead, 
these  results may reflect accumulation of a  mass of insoluble 
polyphenylalanine as  this particular nascent peptide is ex- 
tended. Polyphenylalanine is insoluble in aqueous solvents 
and  is likely to have atypical secondary structure. 
Synthesis of Diphenylalanine-To examine the events oc- 
curring immediately after initiation of polyphenylalanine syn- 
thesis, the AEDANS and CPM derivatives of Phe-tRNA were 
bound to ribosomes, and  then Phe-tRNA was bound nonen- 
zymatically to form the corresponding dipeptides. The fluo- 
rescence was monitored before and  after  the dipeptide was 
formed (Table I). Synthesis of AEDANS-SAcdiPhe-tRNA 
(bound  in the A  site according to  the classical model) causes 
a slight decrease in anisotropy and a marked decrease in 
relative fluorescence intensity compared with that of AE- 
DANS-SAcPhe-tRNA (in  the classical P site). For compari- 
son, data for each aminoacyl-tRNA analogue bound in the A 
site (by blocking the P site with deacylated tRNAPhe) are also 
included. This comparison also indicates that dipeptide for- 
mation causes a large decrease in relative fluorescence of the 
AEDANS as well as a small blue shift  in the emission maxi- 
mum. These data indicate that  the decrease in intensity seen 
during the synthesis of polyphenylalanine initiated with this 
aminoacyl-tRNA derivative (Fig. 1A) occurs during formation 
of the first peptide bond whereas most of the decrease in 
anisotropy occurs at  a later stage. Also, the blue shift  in the 
emission maximum indicates that the environment at the 
dipeptide stage is more hydrophobic than  the original envi- 
ronment. As noted above, during polymerization there is first 
TABLE I 
The effect of dipeptide  formation on  the fluorescence of AEDANS-  
SAcPhe-tRNA and CPM-SAcPhe-tRNA 
The tRNA analogues used in these experiments were bound to 
ribosomes that were not  subsequently isolated  over Sephacryl S-300. 
The anisotropies obtained here are equivalent to those following 
isolation. 
Analogue site Fluorescence flu- anisotropy orescence Em,.," 
intensitv 
nm 
AEDANS-Phe- P 0.280 = L O O  490 
AEDANS-Phe- A 0.273 0.92 490 
AEDANS-diPhe- A 0.271 0.57 489 
CPM-Phe- P 0.372 = L O O  471 
CPM-Phe- A 0.370 0.97 474 
CPM-diPhe- A 0.370 0.96 471 
a Em,nax designates  the wavelength (in  nm) a t  which the maximum 
emission  occurs for that  sample. 
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a red shift in the emission  maximum of the  AEDANS probe 
followed by a  blue shift upon extended polymerization. The 
dipeptide  data  indicate  that  the  red  shift occurs after  forma- 
tion of the  first peptide bond, 
Immediately after  dipeptide  formation,  the  product  is  un- 
reactive  with  puromycin (thus by definition  is  in  the classical 
A site). However, particularly  the  AEDANS-SAcdiPhe-tRNA 
derivative tends to become puromycin-reactive  over long  pe- 
riods of time  (data  not shown). Bergemann  and  Nierhaus (20) 
have observed a similar phenomenon and attributed it to 
spontaneous  translocation. 
Formation of a  dipeptide initiated with CPM-SAcPhe- 
tRNA causes  only  a  slight  decrease in  intensity  in  comparison 
with the monomer in the P site and a slight blue shift in 
comparison  with the monomer  in the A site  (Table I). CPM 
anisotropy is not greatly  affected by dipeptide  formation or 
polypeptide synthesis. The slight decrease in  CPM relative 
fluorescence (Table  I) may be related  to  the  drop  in  intensity 
observed immediately after initiation of polyphenylalanine 
synthesis (Fig. 1B). 
The Effects of Erythromycin  and  Puromycin on Fluorescent 
Analogues of the Mono- and Dipeptide Forms of Phe-tRNA- 
To compare further the initial stages of polyphenylalanine 
formation,  the  dipeptides discussed  in  relation to  Table I were 
synthesized, and  the effects of erythromycin  and  puromycin 
on each were examined. These  data were then compared  with 
the  same  parameters for the  monoaminoacyl-tRNAs bound 
in the A site (Table 11). CPM-SAcPhe-tRNA fluorescence 
increases 17% with  a 6-nm  bathochromic  shift in the emission 
spectrum with erythromycin  present  (with  or  without  puro- 
mycin  added). Puromycin  alone  has a small,  although signif- 
icant, effect on fluorescence intensity and causes a 5-nm 
bathochromic shift in the emission spectrum.  Formation of 
CPM-SAcdiPhe-tRNA has only a minor effect on fluores- 
cence intensity  but does result  in a blue shift  in  the  CPM 
emission spectrum.  Erythromycin once  again causes a 6-nm 
bathochromic  shift in the  CPM emission spectrum  (in  addi- 
tion to  the  3-nm  shift  seen  upon  dipeptide  formation) accom- 
panied by an even greater  increase in  fluorescence intensity. 
This effect again appears to be independent of any effect 
elicited by puromycin. Puromycin, when  added alone  to  the 
bound  CPM-SAcdiPhe-tRNA,  affects  the fluorescence inten- 
sity much as  it  affects the fluorescence intensity of bound 
CPM-SAcPhe-tRNA; however, the emission maximum of the 
dipeptidyl-tRNA analogue  undergoes  only  a 2-nm batho- 
chromic  shift. 
AEDANS-SAcPhe-tRNA is quenched by erythromycin 
with no change  in its emission  maximum  whereas  puromycin 
increases  the  AEDANS fluorescence  183% and  causes a  major 
bathochromic  shift  in  the emission spectrum  (Table 11). 
Bound  simultaneously,  erythromycin  and puromycin  cause  a 
major bathochromic  shift  in  the emission spectrum  and fluo- 
rescence intensity of the  AEDANS  to reach  a value interme- 
diate  to  those achieved with  the individual antibiotics. 
Formation of a dipeptide from AEDANS-SAcPhe-tRNA 
quenches  the fluorescence  from the  probe  and causes  a  small 
bathochromic  shift  in  the  emission maximum. Erythromycin 
further decreases the  AEDANS  intensity,  and puromycin  once 
again increases  the fluorescence intensity  and  causes a bath- 
ochromic shift in the emission spectrum.  The  combination of 
erythromycin  with puromycin, however, results  in  an increase 
in fluorescence intensity to a value greater than that seen 
with  either individual antibiotic with  a change  in  the mission 
maximum  to  an  intermediate level. The  reason  for  this  result 
is unclear;  it may  reflect  a steric  interaction of erythromycin 
with the newly formed  dipeptide,  forcing the  AEDANS group 
closer to  the  bound puromycin. Interestingly,  erythromycin 
appears  to  retard,  but  not completely block, the  spontaneous 
translocation (20) seen with fluorescent diphe-tRNA ana- 
logues. This suggests that erythromycin is able to interact 
with the  nascent  diphenylalanyl-tRNA  to affect its reactivity 
in  the  next  round of peptide  elongation. 
The Effects of Polyphenylalanine Synthesis on Fluorescently 
Labeled Erythromycin-Erythromycin inhibits  the  synthesis 
of most polypeptides, including polylysine (21), on E. coli 
ribosomes. It does not inhibit polyphenylalanine synthesis 
(22) even though the antibiotic remains tightly bound to 
ribosomes on which polyphenylalanine  chains  are being ex- 
tended,  as judged  from the fluorescence anisotropy of eryth- 
romycin  labeled with a coumarin probe,  CITC-erythromycin.' 
The fluorescence intensity of CITC-erythromycin  bound  to 
ribosomes increases as polyphenylalanine  synthesis  is  initi- 
ated and continues to increase as the chain is extended. 
Eventually, values are reached similar to those for CITC- 
erythromycin in organic solvents, such as phenol.' This is 
accompanied by a bathochromic  shift  in  the  CITC emission 
spectrum. Considered with the data presented above, the 
results suggest that polyphenylalanine is synthesized as a 
hydrophobic mass  that  accumulates very close to  the  CITC- 
erythromycin  binding  site  and  the peptidyl transferase  center. 
The  extended  nascent  peptides of either  natural  proteins (23) 
or  p~lyphenylalanine~  prevent  binding of erythromycin  to  the 
ribosomes presumably by blocking the  erythromycin  binding 
site. These  observations  prompt  questions  as  to  the relative 
position of the bound erythromycin and the nascent poly- 
phenylalanine and polylysine chains. The conformation of 
these nascent peptides may be important for erythromycin 
inhibition. How is  it possible  for the  nascent  polyphenylalan- 
TABLE I1 
Comparison of the  effects of erythromycin  and/or  puromycin  on  the  fluorescence of amino-terminal labeled Phe- 
t R N A  or diPhe-tRNA in the puromycin-unreactive  ribosomal  site 
I designates relative fluorescence intensity; A designates fluorescence anisotropy; and Emma, designates the 
wavelength (in  nm) a t  which the  maximum emission  occurs for the sample. 
No addition +Erythromycin +Erythromycin and puromycin +Puromycin Labeled tRNA bound 
Emmax I A Em,., I A Em,.. f A Em,,, I A 
nm  nm  nm  nm 
CPM-SAcPhe- 474 1.00 0.37 468 1.17 0.37 469 1.08 0.37 468 1.17 0.37 
CPM-SAcdiPhe- 471 0.99 0.37 465 1.30 0.37 469" 1.13 0.35 465 1.32 0.37 
AEDANS-SAcPhe- 490 1.00 0.28 490 0.38 0.28 472 2.83 0.28 482 1.42 0.28 
AEDANS-SAcdiPhe- 489 0.57 0.28 489 0.33 0.28 482" 1.61 0.24 486 2.00 0.28 
"These  represent maximum  values since some spontaneous  translocation occurred during  the  time  the  spectra 
were being  measured. 
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ine peptide to escape inhibition by erythromycin,  and more 
importantly why is the  extension of other  peptides blocked? 
A further  indication of the relative position of the  extended 
nascent  polyphenylalanine  chain with respect  to  bound  CITC- 
erythromycin was obtained by allowing polyphenylalanine 
synthesis to proceed on ribosomes to which the antibiotic 
analogue had  been  already bound. We have found  that ribo- 
some-bound  CITC-erythromycin will exchange with free un- 
modified erythromycin." The effect of nascent polyphenyla- 
lanine  on  exchange of ribosome-bound CITC-erythromycin 
with unmodified erythromycin was determined  with  the  re- 
sults shown in Fig. 2. The  time  course for the exchange of 
excess  unlabeled erythromycin for the  bound  CITC-erythro- 
mycin is  plotted.  The  percentage of CITC-erythromycin 
bound to ribosomes was calculated  from  the difference in  the 
fluorescence anisotropy of free and ribosome-bound CITC- 
erythromycin. The maximum  change  in  anisotropy  (from free 
CITC-erythromycin)  upon ribosome binding (A&,,,) and  the 
change in anisotropy at  any given time  after unlabeled eryth- 
romycin addition ( A A )  were entered  into  the following equa- 
tion: 
% (CITC-erythromycin)  bound = AA x 100. 
This  takes  into  account  the  fact  that  bound  CITC-erythro- 
mycin has twice the fluorescence intensity as does CITC- 
erythromycin free in solution  and  that  the observed aniso- 
tropy is an intensity-weighted a ~ e r a g e . ~   T h e  p rcentage of 
CITC-erythromycin  bound  to ribosomes containing  nascent 
polyphenylalanine  chains  remains  greater  than 70% whereas 
that  remaining  bound  to ribosomes without  nascent  peptides 
rapidly approaches 20% (Fig. 2). These  results  indicate  that 
the  nascent  polyphenylalanine  peptide  prevents  exchange of 
CITC-erythromycin.  Probably  this  is  due  to  shielding of the 
bound  antibiotic by the  nascent peptide. 
Initiation of Polylysine Synthesis with dc-tCPM-SAcLys- 
tRNA-Polylysine synthesis was initiated  with  aAc-cCPM- 
SAcLys-tRNA, and the fluorescence anisotropy, intensity, 
and emission  maximum were monitored (Fig. 3)  as was done 
previously for the fluorescent derivatives of AcPhe-tRNA. 
21A,,. - M 
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FIG. 2. Exchange of ribosome-bound CITC-erythromycin 
before and after polyphenylalanine synthesis. CITC-erythro- 
mycin (0.25 N M )  and  AcPhe-tRNA (1 p M )  were bound to  ribosomes 
(1 PM), and then other components required for polyphenylalanine 
synthesis were added except that the S-150 enzyme fraction was 
omitted from the control to prevent polymerization. The samples 
were incubated a t  37 "C  for 30 min. Unlabeled erythromycin (5 p~ 
final concentration) was added to both sample and control, and 
changes in fluorescence anisotropy were monitored over time. The 
fraction of CITC-erythromycin  remaining  bound was determined by 
the equation: fraction bound = MA/21Am,, - M. Open symbols, 
erythromycin exchange on ribosomes without  nascent peptides. 
Closed symbols, exchange  on  ribosomes containing  nascent  polyphen- 
ylalanine  chains  estimated to be approximately 30 amino acids long. 
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Wavelength, nm 
FIG. 3. Changes in the  fluorescence  of aAc-tCPM-SAcLys- 
tRNA after  initiation of polylysine  synthesis. In panel A,  ani- 
sotropy (open symbols) and relative  fluorescence (closed symbols) were 
monitored for control samples (squares) and for samples in which 
polylysine synthesis was induced (circles), as was shown in Fig. 1B 
for CPM-SAcPhe-tRNA.  In panel B,  the emission spectra for aAc- 
tCPM-SAcLys-tRNA free in solution (. . . . .), bound to ribosomes 
(-), and after polylysine synthesis was completed (- - -) are 
shown. The nascent polylysine peptides were considerably shorter 
than  the  nascent  polyphenylalanine  peptides described in Fig. 1 (on 
the order of 10-15 lysine residues long); however, these polylysine 
peptides  can  be  compared  with  the  early  events  that occur during 
polyphenylalanine synthesis (about 10 min aft.er polyphenylalanine 
initiation). 
Upon  binding  to ribosomes, the  anisotropy of the  Lys-tRNA 
analogue  increases from 0.14 to 0.34 with  a 42% increase in 
relative  fluorescence  (Fig. 3A).  These  data  are  similar  to  those 
seen for CPM-SAcPhe-tRNA upon binding  to ribosomes  (Fig. 
1B). aAc-&PM-SAcLys-tRNA  binding causes  a batho- 
chromic shift in the  CPM emission maximum from 482 to 
476 nm (Fig. 3B), which is also similar  to  the  effect ribosome 
binding has upon CPM-SAcPhe-tRNA (Fig. 1D). At this 
point,  the  poly(A)-directed  synthesis of polylysine could be 
initiated  to follow the  fate of the  amino-terminal  CPM  as  it 
was extended  on a  charged  hydrophilic nascent  peptide (Fig. 
3A). As with polyphenylalanine  synthesis, polylysine synthe- 
sis results in an initial drop in CPM anisotropy, but the 
decrease is  much larger wit,h polylysine. Unlike the  result  with 
polyphenylalanine synthesis, however, further extension of 
the nascent polylysine causes an even greater decrease in 
anisotropy  rather  than  an increase  (Fig. 3 A ) .  This  apparent 
increase in the mobility of the amino terminus of nascent 
polylysine is accompanied by a  decrease  in intensity for CPM 
fluorescence and a  hypsochromic shift in the emission  maxi- 
mum (Fig. 3B) .  The  lengths of the polylysine chains in these 
experiments were only in  the  range of 10-15 amino acids but 
were well beyond the  point  at which the  anisotropy of nascent 
polyphenylalanine  had  started  to rise (cf. Fig. 1, A and B ) .  In 
addition, at  no  point in the  synthesis of polyphenylalanine 
initiated with CPM-SAcPhe-tRNA (Fig. 1B) did the aniso- 
tropy drop as low as  it  did  during polylysine synthesis. 
Despite forming a relatively short nascent peptide, the 
results indicate that the probe on the amino terminus of 
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nascent polylysine moves quickly into a  more polar  environ- 
ment in which it has a high degree of mobility. From this 
point  there  appears  to be very little  change  in  the  environment 
of the probe as the nascent peptide is extended. This is 
inconsistent with  polylysine entering a constricted region of 
the ribosome which is 30-35 amino acids in length before 
exiting at a site  distal  to  the peptidyl transferase  center. 
Synthesis of Dilysine and  the Effects of Erythromycin  and 
Puromycin on the Fluorescent  Mono- and Dilysyl-tRNAs-As 
was done previously with the  fluorescent analogues of AcPhe- 
tRNA  (Table I), nAc-cCPM-SAcLys-tRNA was used to  form 
dipeptidyl-tRNA nonenzymatically to  examine  the effects the 
formation of the  first  peptide  bond  has  on  CPM fluorescence 
(Table 111). The  changes  in fluorescence properties associated 
with dilysine formation only  remotely  reflect the  early  stages 
that occur after  the  initiation of polylysine synthesis (shown 
in Fig. 3). Dilysine formation  causes  no  change  in  anisotropy 
although  it does cause a hypsochromic shift  in  the emission 
and a  relatively small decrease in fluorescence intensity 
(Table 111). Polylysine synthesis  results  in a rapid, substantial 
drop in anisotropy  and decrease in fluorescence intensity (Fig. 
3A) accompanied by a  relatively  large  hypsochromic shift  in 
the emission spectrum of CPM (Fig. 3B). Presumably, the 
relatively large changes observed with polylysine synthesis 
reflect extension of the  nascent  peptide beyond the  dipeptide 
stage. 
For further  examination of the  initial  steps  in polylysine 
synthesis,  the mono- and dilysyl-tRNA analogues (each bound 
in  the classical  A site) were incubated  with  erythromycin  and/ 
or puromycin, and  the effects of antibiotic  binding  on fluores- 
cence were monitored. aAc-cCPM-SAcLys-tRNA behaves 
somewhat  like CPM-SAcPhe-tRNA  (Table 11) upon  erythro- 
mycin addition, puromycin addition,  and  the  addition of both 
erythromycin and puromycin (Table 111). Erythromycin (+ 
puromycin) causes a 4-nm bathochromic shift in the CPM 
emission spectrum whereas  puromycin alone only  caused  a 2- 
nm  shift. Unlike the  results with CPM-SAcPhe-tRNA, when 
aAc-tCPM-SAcLys-tRNA was used  to  form dilysine, a 3-nm 
hypsochromic shift was observed in  the emission maximum. 
However, relative to  the  dipeptide emission spectrum,  eryth- 
romycin (+ puromycin) causes a 5-nm bathochromic shift 
whereas  puromycin alone  continues  to cause  a 2-nm  batho- 
chromic shift. These data indicate that erythromycin once 
again interacts more  strongly  with the  dipeptidyl-tRNA  than 
with monoaminoacyl-tRNA. 
Initiation of Polylysine Synthesis  in  the  Presence of CITC- 
TABLE 111 
The effect of dilysine formation  on the fluorescence of nAc-cCPM- 
SAcLys-tRNA and a comparison of the effects of erythromycin and/ 
or puromycin on the mono- and dilysyl-tRNA analogues 
Site Fluorescence Relative 
intensitv 
anisotropy fluorescence Ern,.," 
nm 
CPM-Lys- P 0.340 ~ 1 . 0 0  476 
CPM-LYS- A 0.338 1.10 475 
CPM-diLys- A 0.345 0.97 478 
CPM-Lys-  +erythromycin A 0.340 1.13 471 
CPM-Lys- +puromycin A 0.340 1.09 473 
CPM-Lys-  +erythromycin A 0.340 1.14 471 
CPM-diLys-  +erythromycin A 0.330 1.10 473 
CPM-diLys- +puromycin A 0.340 1.03 476 
CPM-diLys  +erythromycin A 0.350 1.08 473 
+puromycin 
+puromycin 
"Em,,,, designates the wavelength (in  nm)  at which the  maximum 
emission  occurs for that  sample. 
Erythromycin-Polylysine synthesis  is  inhibited by erythro- 
mycin causing  the  accumulation of di-  and  tripeptides (21). 
Polylysine synthesis was initiated with diacetyl-Lys-tRNA  in 
the presence of bound CITC-erythromycin to compare the 
effects on CITC fluorescence with those produced by the 
synthesis of polyphenylalanine. When  CITC-erythromycin  is 
bound  to ribosomes, its fluorescence intensity  increases  sub- 
stantially with a bathochromic shift in the CITC emission 
spectrum (Fig. 4). The binding of diacetyl-Lys-tRNA then 
results  in a  very slight decrease in  intensity  and hypsochromic 
shift  in  the emission  maximum. When polylysine synthesis is 
initiated,  the  CITC emission spectrum  shifts back toward  the 
blue with a  small increase  in fluorescence intensity (Fig. 4). 
The  result  is  similar  to  but less pronounced  than  that  seen 
with polyphenylalanine  synthesis.  During  the  latter process, 
nascent  peptides of 100 or more amino acids may be formed 
whereas only very short lysine peptides are formed in the 
presence of the  antibiotic (see below) or its fluorescent  deriv- 
ative. The data appear to indicate that the nascent lysine 
peptide moves very close to  the  bound  erythromycin before 
its  extension  is blocked. Polyphenylalanine  synthesis,  on  the 
other  hand, is somehow able  to bypass erythromycin blockage. 
The Effect of Erythromycin on the Fluorescence of d e -  
&PM-SAcLys-tRNA before and after Polymerization-The 
fluorescence properties of CPM-Lys-tRNA  in various stages 
of polylysine synthesis  in  the  presence  and absence of eryth- 
romycin were examined  (Table IV). Binding of aAc-cCPM- 
SAcLys-tRNA  to ribosomes results  in  the  characteristic  in- 
50 ' 1 
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FIG. 4. The effect of polylysine synthesis on fluorescence 
from CITC-erythromycin. The emission spectra of CITC-eryth- 
romycin free in solution (unbroken line), bound to 70 S ribosomes 
(long dashed  line),  bound  to 70 S ribosomes  with  Ac2Lys-tRNA (short 
dashed  line),  and  after  initiation f polylysine synthesis  (dotted  line). 
TABLE IV 
The effect of erythromycin  on the fluorescence of dc-eCPM-SAcLys- 
tRNA before and after polymerization 
Position of tRNA 
aAc-cCPM-SAcLvs" Dosition Anisotropy  Intensity Ern,.. 
Free  in  solution 
Bound  to ribosome 
Bound + erythromycin' 
First in poly (Lys) 
First  in poly (Lys) + ery- 
thromycin' 
First  in poly (Lys)" 




0.139  1.00  482 
P 
0.340 1.42 476 
0.343 1.55 475 
0.170 1.20 480 
0.221 1.50 477 
0.226 0.92 480 
0.266 1.40 478 
"Used as  the  aAc-aminoacyl-tRNA. 
'When used, erythromycin a t  5.0 pM was bound simultaneously 
with  the  tRNA. 
'After incubation for polylysine synthesis, the reaction mixtures 
were chromatographed  on  Sephacryl S-300 to  seperate peptidyl tRNA 
bound  to ribosomes  from unbound eCPM-SAcLys-species. 
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crease in fluorescence intensity  and  anisotropy  with a blue 
shift  in  the  CPM emission spectrum.  Erythromycin  binding 
causes a further,  although  slight, blue shift  in  the emission 
maximum with little  or  no  change  in  anisotropy.  Initiation of 
polylysine synthesis with the CPM residue on the amino- 
terminal  amino acid results  in a large drop  in  anisotropy  with 
a significant  decrease  in  fluorescence intensity  and a  red shift 
in  the emission spectrum (see  also Fig. 3, A and B). However, 
the otherwise identical initiation of polylysine synthesis in 
the presence of erythromycin  (concentration of erythromycin 
> ribosome >> aAc-tCPM-SAcLys-tRNA)  results  in a some- 
what  smaller decrease in  anisotropy,  essentially  no decrease 
in fluorescence intensity,  and only  a small hypsochromic shift 
in  the emission maximum  (Table  IV,  top five entries).  This 
erythromycin effect correlates with  a 50% inhibition of  ["C] 
lysine incorporation  (data  not  shown). 
To examine more closely the effect of polylysine synthesis 
on  amino-terminal fluorescence,  ribosomes  with attached  nas- 
cent  chains were isolated by gel filtration  chromatography.  In 
this way it  is possible to  measure fluorescence  from  only aAc- 
tCPM-SAcLys-tRNA  incorporated  into  polylysine-tRNA 
which remains  bound  to  the ribosomes (Table IV, bottom two 
entries).  In comparison to free aAc-tCPM-SAcLys-tRNA,  the 
bound  aminoacyl-tRNA  analogues show increased  anisotropy, 
increased relative fluorescence intensity and a significant 
bathochromic shift in fluorescence. Initiation of polylysine 
synthesis  in  the  presence of erythromycin  results  in a  decrease 
in  anisotropy  and a slight  red  shift  in  the emission maximum, 
indicating that these are characteristics of the ribosome- 
bound  short  nascent peptide  produced when  this  antibiotic  is 
bound  and  are  not simply due  to release  of a population of 
small  peptides  either  free or as peptidyl-tRNA. The fluores- 
cence intensity of these short peptides, however, does not 
change appreciably,  suggesting that  the  attached fluorophore 
remains in the vicinity of the hydrophobic peptidyl  transfer- 
ase  center. A further  drop  in  anisotropy  and a  relatively  large 
decrease in  intensity accompanied by a further hypsochromic 
shift of CPM fluorescence from  attached  full-length polyly- 
sine  chains also  suggest that  erythromycin  causes  the  amino- 
terminal  amino acid containing  CPM  to  remain  in  the vicinity 
of the peptidyl transferase  center  (Table  IV). 
In  addition  to  its effects on fluorescence, erythromycin also 
appears  to  be  limiting  the  amount of ["Cllysine in  the poly- 
lysine that remains attached to the ribosomes (data not 
shown). The isolated ribosome fractions were treated with 
NaOH  to release  lysine peptides  from  tRNA,  neutralized  with 
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FIG. 5. Chromatographic profile of the products of polyly- 
sine synthesis on Sephadex G-15. Polylysine synthesis was car- 
ried out  in  the presence (closed circles) or absence (open circles) of 
excess erythromycin as  described under  "Experimental Procedures." 
Ribosome-bound peptidyl-tRNA was hydrolyzed with 0.2 M NaOH. 
Then the fraction was neutralized with glacial acetic acid prior to  
application  to  the  column.  The closed diamonds represent  the  position 
a t  which  free ["Cllysine elutes  from  the  column.  Fraction 10 is at  the 
void volume of the  column. 
glacial acetic  acid, and clarified by centrifugation.  The sample 
containing [l4C]1ysine peptides was fractionated  on  Sephadex 
G-15 to separate products by size. The results with lysine 
peptides formed in  the  presence  or  absence of erythromycin 
are shown in Fig. 5. Also shown  is  the profile for free [''CC] 
lysine. The results  indicate  that  the majority of the ribosome- 
bound lysine peptides  synthesized  in  the absence of erythro- 
mycin are larger than 1,000 in molecular weight. This would 
correspond  to at least 5 lysyl residues with a  single CPM (M, - 400) attached  and fits well with an  estimated  minimal  chain 
length of 10. Conversely,  lysine peptides formed in  the  pres- 
ence of erythromycin  are appreciably smaller  and  are eluted 
only  slightly  before ['4C]lysine (Fig. 5 ) .  If only the  amount of 
[14C]lysine in  the higher  molecular  weight  radioactive  peptides 
is considered, erythromycin  appears  to  inhibit polylysine syn- 
thesis  about 90%. Further  determinations of the  exact poly- 
lysine chain  length  in  the  presence of erythromycin have not 
given clear  results,  but  the  data do appear  to agree  with the 
results of Otaka  and  Kaji (21) that  erythromycin  causes  an 
accumulation of di-  and  tripeptides. 
DISCUSSION 
Peptides  are elongated at  a rate of up  to 10 residues/s i n  
vivo; however, the i n  vitro system used in  these  studies  elon- 
gates at  a  considerably slower rate.  This  is  advantageous  in 
that elongation is slowed to a rate at which we can easily 
detect  various  changes  in  the  amino  terminus by fluorescence 
techniques.  Despite  the relatively slow rate of elongation i n  
uitro, we were still forced to  carry  out  these  experiments at 
20 "C since at 37 "C  the  changes occur too rapidly to  measure 
accurately. After  the  incorporation of [14C]phenylalanine  and 
[14C]lysine into their respective nascent peptides, we have 
determined  that each is  elongating at a nearly  linear  rate over 
the  times  reported  here  (data  not shown). This  rate is such 
that, for polyphenylalanine, nascent  chains of greater  than 
100 amino  acids  are only  produced after 60 min.  The  rate for 
polylysine synthesis  is considerably less. Although the  kinet- 
ics of elongation i n  vivo are  quite  different from the  kinetics 
of this  system,  the  results  obtained here should  nevertheless 
be valid as a tool for examining ribosome structure and 
nascent  peptide  conformation  during elongation. 
The decrease in fluorescence anisotropy which occurs as 
peptide synthesis is initiated with the peptidyl-tRNA ana- 
logues appears  to reflect increased  movement of the  probe as 
it leaves the peptidyl transferase center. The apparent de- 
crease in the  constraints  on  the movement of the probe is 
associated  with a change  in fluorescence quantum yield and 
emission  maximum,  indicating  that  the  probe  enters a  more 
hydrophilic environment.  Some of the  intensity  changes occur 
very  rapidly as  the  first  peptide  bond is formed, as  indicated 
by experiments  in which only a dipeptide is formed, but  the 
anisotropy  changes occur a t  a later stage of polymerization. 
Fluorescence from  nascent lysine peptides  remains at  levels 
established immediately after initiation as the peptides are 
extended.  There is no  indication  that  the probe at  the  amino 
terminus for the  nascent peptide enters a tunnel or is con- 
strained by the ribosome. The  results  appear  to  indicate  that 
nascent polylysine peptides  extend from the  peptidyl  trans- 
ferase  center directly into  the  aqueous  environment  surround- 
ing the ribosome. At the very least, if polylysine does enter a 
channel  or  tunnel,  the  tunnel  must  be very large and  hydro- 
philic in nature. If it does not enter a tunnel into which 
natural  nascent  peptides  are normally channeled,  this may be 
related  to  the  fact  that polylysine a t  neutral  pH  exists mainly 
as a random coil (24). 
The  situation for polyphenylalanine is quite different.  After 
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an  initial drop,  fluorescence anisotropy  increases at a decreas- 
ing  rate  throughout  the  incubation period, apparently  due  to 
extension of the  nascent polyphenylalanine chain.  This  in- 
crease  in anisotropy  is  associated with  a change  in  quantum 
yield and a  blue shift  in emission  maximum consistent with 
the probe entering  an increasingly  hydrophobic environment. 
We  interpret  these  results  as  indicating  that as the  nascent 
peptide  is  extended,  polyphenylalanine  is  accumulated,  prob- 
ably  as  an insoluble mass of undetermined  structure,  in  the 
immediate vicinity of the peptidyl transferase center. This 
hypothesis is strengthened greatly by the  results with CITC- 
erythromycin. This derivative binds to ribosomes with ap- 
proximately the same affinity as unlabeled erythromycin, 
apparently at  the  same  binding  site  on 50 S subunits.  CITC- 
erythromycin bound to  empty ribosomes is exchanged  readily 
with unlabeled erythromycin.  The exchange can be monitored 
effectively by changes in CITC-fluorescence anisotropy or 
fluorescence intensity.  Both unlabeled erythromycin  and 
CITC-erythromycin  inhibit polylysine synthesis  but have lit- 
tle  or no effect on  polyphenylalanine  synthesis. The synthesis 
of polyphenylalanine on ribosomes to which CITC-erythro- 
mycin is bound causes  an  increase  in  the  quantum yield of its 
fluorescence, indicating that the environment of the probe 
becomes  increasingly  hydrophobic as  the  nascent  peptide is 
extended. The fluorescence anisotropy of the  CITC-erythro- 
mycin remains high, demonstrating  that  the  antibiotic  is  not 
displaced from the ribosome by the nascent peptide. Most 
important for the  hypothesis  that  the  nascent  polyphenyla- 
lanine is accumulated  as  an insoluble mass  near  the peptidyl 
transferase  center  is  that  the exchange of CITC-erythromycin 
with unlabeled erythromycin decreases as  nascent  peptide is 
formed. We  interpret  this  result, considered  with the  apparent 
increase  in the hydrophobicity of the  environment  around  the 
CITC-erythromycin,  to  indicate  that  the  antibiotic  is shielded 
directly by the  nascent peptide. 
The  results considered above prompt  questions  about why 
polyphenylalanine synthesis  is  not  inhibited by erythromycin 
and about the physical characteristics and function of the 
erythromycin  binding site. We suggest that  the lack of inhi- 
bition is  related  to  the  unusual chemical and physical char- 
acteristics of polyphenylalanine  compared with  those of most 
other polypeptides. It  appears likely that  the  nascent poly- 
phenylalanine peptide may collapse as it is formed into an 
insoluble mass lacking discrete  secondary  structure.  In  con- 
trast, most natural peptides may take  the form of an  a-helix 
as they  are  extended  on a ribosome. Lim and  Spirin (25) have 
presented persuasive arguments that an a-helix inevitably 
would be formed by the  corotational movement of the  nascent 
peptide with the  tRNA  as a  consequence of the  codon-anti- 
codon interaction  as  the  tRNA  and  mRNA  are moved through 
the ribosome. 
The  function of the  erythromycin  binding  site  is unclear. It 
is very close to the peptidyl transferase center, apparently 
within a distance occupied by a di-  or  tripeptide. It  appears 
to  be relatively  hydrophobic  in nature,  as judged by changes 
in fluorescence from CITC-erythromycin which occur upon 
binding to ribosomes, and is occupied by the  nascent  peptide 
after it is extended beyond a critical length. It has been 
suggested (7) that  erythromycin may block the  tunnel  span- 
ning  the large  ribosomal subunit (5 )  through which the  nas- 
cent  peptide may be channeled  to reach the  exit domain on 
the  outer surface of the  subunit.  This is a  provocative hypoth- 
esis, but  the  data  presented here  provide very little  indication 
as  to  whether  or  not  it is correct. Erythromycin blocks the 
extension of nascent polylysine chains; however, it  appears 
that these nascent peptides may extend directly into the 
aqueous environment from the peptidyl transferase center. 
Thus,  inhibition of polylysine synthesis would not be antici- 
pated if erythromycin blocks the entrance to the tunnel. 
Perhaps there is a channel or obligatory path immediately 
adjacent to the peptidyl transferase center through which 
most  peptides  must  pass even before they  enter  the proposed 
tunnel. Erythromycin may block this path. Unfortunately, 
these suggestions and  the  data  presented above provide little 
indication of  how the  nascent  peptide is channeled from the 
peptidyl transferase center to the exit domain for proteins 
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